"监狱不是这些囚犯的答案":如何应对监狱中的甲基胺使用情况
Rosemary Ricciardelli1, Matthew S Johnston1, Katharina Maier2
1Fisheries and Marine Institute, School of Maritime Studies, Memorial University of Newfoundland, St. John's, Canada.
International journal of prison health
|August 26, 2024
概括
监狱工作人员需要更好的政策,培训和资源来管理监狱中的甲基胺使用和戒断. 加强支持对于在惩戒系统内员工的福祉和安全至关重要.
科学领域:
- 惩戒卫生卫生机构
- 公共卫生 公共卫生
- 成 药物 药物 药物 药物
背景情况:
- 监狱系统在监禁人员中管理甲基胺使用方面面临重大挑战.
- 甲基胺使用对惩戒工作环境和员工幸福感产生影响.
研究的目的:
- 确定必要的资源和政策,以协助惩戒工作人员管理甲基胺使用.
- 检查甲基胺对惩戒工作和工作人员福祉的影响.
主要方法:
- 一项在线调查对加拿大马尼托巴省的269名惩戒工作人员进行了调查.
- 通过使用NVivo软件的新兴主题方法分析了回复.
主要成果:
- 惩戒工作者认为目前对甲基胺使用和戒断管理的政策不够.
- 每月与戒除甲基胺的人接触都会带来安全风险.
- 工人希望获得更多的教育,培训,人力/物力资源,医疗干预和专业计划.
结论:
- 监狱工作人员的观点强调了监狱内管理甲基胺使用的关键差距.
- 该研究强调需要改善监狱生活和重新入境的政策,知识和支持系统.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
451
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
451
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
169
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
169
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Phase II Reactions: Methylation Reactions
161
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
161
Adrenergic Agonists: Mixed-Action Agents
691
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
691
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K


